Phase II Clinical Study: A Randomized, Open, and Dose Ranging Study to Evaluate the Efficacy and Safety of DLBS-1425 in Subjects With Metastatic / Advanced (Stage IIIB / IV) Breast Cancer.
Phase of Trial: Phase II
Latest Information Update: 17 Oct 2012
At a glance
- Drugs Phaleria macrocarpa (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 09 Sep 2011 Planned end date changed from 1 Dec 2011 to 1 Apr 2012 as reported by ClinicalTrials.gov.
- 27 Dec 2010 Actual initiation date changed from Apr 2010 to Aug 2009 as reported by ClinicalTrials.gov.
- 27 Dec 2010 Planned end date changed from 1 Feb 2011 to 1 Dec 2012 as reported by ClinicalTrials.gov.